by October Gallery
(Reuters) – Sarepta Therapeutics Inc said on Thursday it was informed that an adverse event report was erroneously submitted to the U.S. health regulator regarding an ongoing study of the…
(Reuters Health) – People who eat a healthy, mostly plant-based diet may be less likely to develop heart disease and to die from it than those who consume lots of…
(Reuters) – An FDA advisory panel on Wednesday voted in favor of Gilead Sciences Inc’s combination drug to reduce the risk of sexually acquired HIV infection in men and transgender…
GOMA, Democratic Republic of Congo (Reuters) – Three Congolese doctors have been arrested for allegedly planning an attack on a hospital that killed a senior World Health Organization (WHO) epidemiologist…
(Reuters Health) – People with more supermarkets and grocery stores close to home and workers who pass more fast food restaurants on their commute have higher odds of being overweight…
LOS ANGELES (Reuters) – Gilead Sciences Inc (GILD.O) hopes to soon introduce a pricey new pill to prevent HIV in people at risk of contracting the infection, but the drugmaker…
(Reuters Health) – Major surgery may be tied to a small decline in cognitive functioning when we are older – equivalent, on average, to less than five months of natural…
FILE PHOTO: A Gilead Sciences, Inc. office is shown in Foster City, California, U.S. May 1, 2018. REUTERS/Stephen Lam (Reuters) – The U.S. Centers for Medicare and Medicaid Services (CMS)…
TORONTO (Reuters) – Canada’s main pharmaceutical lobby group has urged the government not to wait for drug shortages before responding to U.S. plans to import Canadian drugs, according to documents…
TEL AVIV (Reuters) – Israel’s Nobio Ltd said on Monday it received approval from the U.S. Food and Drug Administration to market its anti-bacterial composite designed to remain in the…